These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
294 related items for PubMed ID: 29982573
1. Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15. Golden AR, Adam HJ, Karlowsky JA, Baxter M, Nichol KA, Martin I, Demczuk W, Van Caeseele P, Gubbay JB, Lefebvre B, Levett PN, Zahariadis G, Haldane D, Gad R, German G, Gilmour MW, Mulvey MR, Hoban DJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA). J Antimicrob Chemother; 2018 Jul 01; 73(suppl_7):vii20-vii31. PubMed ID: 29982573 [Abstract] [Full Text] [Related]
2. Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-15. Adam HJ, Golden AR, Karlowsky JA, Baxter MR, Nichol KA, Martin I, Demczuk W, Mulvey MR, Gilmour MW, Hoban DJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA). J Antimicrob Chemother; 2018 Jul 01; 73(suppl_7):vii12-vii19. PubMed ID: 29982572 [Abstract] [Full Text] [Related]
3. Invasive Streptococcus pneumoniae in Canada, 2011-2014: Characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F. Golden AR, Adam HJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA). Vaccine; 2016 May 17; 34(23):2527-30. PubMed ID: 27085174 [Abstract] [Full Text] [Related]
4. Assessment of multidrug resistance, clonality and virulence in non-PCV-13 Streptococcus pneumoniae serotypes in Canada, 2011-13. Golden AR, Adam HJ, Gilmour MW, Baxter MR, Martin I, Nichol KA, Demczuk WH, Hoban DJ, Zhanel GG. J Antimicrob Chemother; 2015 Jul 17; 70(7):1960-4. PubMed ID: 25761605 [Abstract] [Full Text] [Related]
5. Whole genome characterization of Streptococcus pneumoniae from respiratory and blood cultures collected from Canadian hospitals before and after PCV-13 implementation in Canada: Focus on serotypes 22F and 33F from CANWARD 2007-2018. Golden AR, Adam HJ, Baxter M, Martin I, Demczuk W, Mulvey MR, Karlowsky JA, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA). Vaccine; 2021 Sep 15; 39(39):5474-5483. PubMed ID: 34454785 [Abstract] [Full Text] [Related]
6. Genomic investigation of the most common Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-2020. Golden AR, Adam HJ, Karlowsky JA, Baxter M, Schellenberg J, Martin I, Demczuk W, Minion J, Van Caeseele P, Kus JV, McGeer A, Lefebvre B, Smadi H, Haldane D, Yu Y, Mead K, Mulvey MR, Zhanel GG. J Antimicrob Chemother; 2023 May 03; 78(Suppl 1):i26-i36. PubMed ID: 37130587 [Abstract] [Full Text] [Related]
7. Invasive pneumococcal disease caused by serotypes 22F and 33F in Canada: the SAVE study 2011-2018. Golden AR, Fear T, Baxter M, Adam HJ, Martin I, Demczuk W, Karlowsky JA, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA). Diagn Microbiol Infect Dis; 2021 Oct 03; 101(2):115447. PubMed ID: 34192638 [Abstract] [Full Text] [Related]
8. Population structure and drug resistance patterns of emerging non-PCV-13 Streptococcus pneumoniae serotypes 22F, 15A, and 8 isolated from adults in Ontario, Canada. Duvvuri VR, Deng X, Teatero S, Memari N, Athey T, Fittipaldi N, Gubbay JB. Infect Genet Evol; 2016 Aug 03; 42():1-8. PubMed ID: 27071529 [Abstract] [Full Text] [Related]
9. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016. Zhao C, Li Z, Zhang F, Zhang X, Ji P, Zeng J, Hu B, Hu Z, Liao K, Sun H, Zhang R, Cao B, Zhuo C, Jia W, Mei Y, Chu Y, Xu X, Yang Q, Jin Y, Fu Q, Xu X, Li H, Wang L, Ni Y, Liang H, Wang H. BMC Infect Dis; 2017 Dec 29; 17(1):804. PubMed ID: 29284419 [Abstract] [Full Text] [Related]
10. Multistate population and whole genome sequence-based strain surveillance of invasive pneumococci recovered in the USA during 2017. Varghese J, Chochua S, Tran T, Walker H, Li Z, Snippes Vagnone PM, Lynfield R, McGee L, Li Y, Metcalf BJ, Pilishvili T, Beall B. Clin Microbiol Infect; 2020 Apr 29; 26(4):512.e1-512.e10. PubMed ID: 31536818 [Abstract] [Full Text] [Related]
11. Evolution and molecular characterization of macrolide-resistant Streptococcus pneumoniae in Canada between 1998 and 2008. Wierzbowski AK, Karlowsky JA, Adam HJ, Nichol KA, Hoban DJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance. J Antimicrob Chemother; 2014 Jan 29; 69(1):59-66. PubMed ID: 23970485 [Abstract] [Full Text] [Related]
12. Genetic analysis of invasive pneumococcal isolates from children in Ontario, Canada, 2007-2012. Deng X, Arya G, Memari N, Mackenzie R, MacMullin G, Low DE, Pillai DR, Gubbay JB. Pediatr Infect Dis J; 2015 Jun 29; 34(6):594-8. PubMed ID: 25831418 [Abstract] [Full Text] [Related]
13. Baseline epidemiology of Streptococcus pneumoniae serotypes in Canada prior to the introduction of the 13-valent pneumococcal vaccine. Adam HJ, Karlowsky JA, Nichol KA, Gilmour MW, Hoban DJ, Embree J, Zhanel GG. Microb Drug Resist; 2012 Apr 29; 18(2):176-82. PubMed ID: 22204595 [Abstract] [Full Text] [Related]
14. Rise of multidrug-resistant Streptococcus pneumoniae clones expressing non-vaccine serotypes among children following introduction of the 10-valent pneumococcal conjugate vaccine in Bulgaria. Setchanova L, Alexandrova A, Pencheva D, Sirakov I, Mihova K, Kaneva R, Mitov I. J Glob Antimicrob Resist; 2018 Dec 29; 15():6-11. PubMed ID: 29803821 [Abstract] [Full Text] [Related]
15. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014. Nakano S, Fujisawa T, Ito Y, Chang B, Suga S, Noguchi T, Yamamoto M, Matsumura Y, Nagao M, Takakura S, Ohnishi M, Ihara T, Ichiyama S. Vaccine; 2016 Jan 02; 34(1):67-76. PubMed ID: 26602268 [Abstract] [Full Text] [Related]
16. PCR-based discrimination of emerging Streptococcus pneumoniae serotypes 22F and 33F. Gillis HD, Demczuk WHB, Griffith A, Martin I, Warhuus M, Lang ALS, ElSherif M, McNeil SA, LeBlanc JJ. J Microbiol Methods; 2018 Jan 02; 144():99-106. PubMed ID: 29162393 [Abstract] [Full Text] [Related]
17. Genetic diversity of pneumococcal surface protein A (PspA) in paediatric isolates of non-conjugate vaccine serotypes in Japan. Kawaguchiya M, Urushibara N, Aung MS, Morimoto S, Ito M, Kudo K, Kobayashi N. J Med Microbiol; 2018 Aug 02; 67(8):1130-1138. PubMed ID: 29927374 [Abstract] [Full Text] [Related]
18. Serological and molecular capsular typing, antibiotic susceptibility and multilocus sequence typing of Streptococcus pneumoniae isolates from invasive and non-invasive infections. Zhang YJ, Chen YS, Wang ZW, Li YQ, Wang DX, Shang Y, Fu RR, Hu YH, Geng R, Wei LP, Yang JP, Li JS, Yu Q, DU J, Gao ZC. Chin Med J (Engl); 2013 Jun 02; 126(12):2296-303. PubMed ID: 23786942 [Abstract] [Full Text] [Related]
19. Acute otitis media caused by Streptococcus pneumoniae serotype 19A ST320 clone: epidemiological and clinical characteristics. Chi H, Chiu NC, Huang FY, Hsu CH, Lee KS, Huang LM, Hsieh YC. J Microbiol Immunol Infect; 2018 Jun 02; 51(3):337-343. PubMed ID: 28087317 [Abstract] [Full Text] [Related]
20. Association of pili with widespread multidrug-resistant genetic lineages of non-invasive pediatric Streptococcus pneumoniae isolates. Alexandrova AS, Pencheva DR, Setchanova LP, Gergova RT. Acta Microbiol Immunol Hung; 2022 Sep 16; 69(3):177-184. PubMed ID: 36094859 [Abstract] [Full Text] [Related] Page: [Next] [New Search]